ID ...... Создание производства нанопрепаратов

• Дата добавления

  08.09.2014

• Последнее обновление

  28.02.2023

• Тип работ

  Новое строительство

• Местоположение

  ······ ················ ········

• Полное описание

  ············ ············ ······ ·········· ···· ·········· ·········· ·········· ······ ···· ······ ················ ········ ········ ·········· ·········· ·············· ·············· ············ ············ ·············· ············ ················ ·········· ············ ················ ···· ·············· ················ ······ ············ ········ ···· ········ ················ ·········· ···· ······ ············ ········ ·············· ·········· ·········· ················ ······ ···· ·········· ·············· ·········· ················ ···· ·············· ········ ···· ·········· ········ ······ ·············· ······ ········ ······ ·········· ········ ···· ········ ········ ·············· ················ ············ ······ ············ ············ ········ ················ ···· ·········· ······ ······ ······ ···· ···· ········ ················ ················ ·············· ············ ················ ······ ········ ········ ·············· ············ ················ ············ ················ ············ ················ ······ ······ ·········· ······ ······ ········ ················ ············ ·········· ······ ············ ········ ············ ···· ············ ···· ············ ············ ·············· ·············· ······ ·········· ······ ···· ············ ······ ···· ·············· ·············· ············ ·········· ·········· ·············· ·········· ···· ········ ······ ················ ················ ················ ······ ············ ·········· ················ ········ ············ ················ ················ ················ ·············· ·············· ·············· ················ ······ ·········· ·············· ······ ················ ········ ················ ······ ············ ·········· ······ ·········· ················ ·············· ················ ·············· ······ ·············· ············ ·········· ················ ···· ········ ······ ················ ············ ········ ···· ················ ······ ········

• Производственная площадка

  ·········· ·········· ················ ·········· ·············· ·········· ··········
  

  Объем инвестиций активных проектов: ·········· ················ руб.

  
  Топ-5 активных проектов площадки
  

  1. ID ·············· ········ ·············· ···· ···· (·························· ······················ ·· ···················· ··············) (···················· ··············) — ········· млрд руб

  2. ID ·············· ········ ······ ················ ············ (····························) (···················· ··············) — ········· млрд руб

  3. ID ················ ·········· ·············· ······ (····························) (···················· ··············) — ········· млрд руб

  4. ID ·········· ················ ············ ················ (····························) (···················· ··············) — ········· млрд руб

  5. ID ············ ········ ·············· ········ ········ (·························· ···· ············ ································ ·· ········ ········) (···················· ··············) — ········· млрд руб

• Краткое описание

  В Центральном федеральном округе планируется строительство производства нанопрепаратов. В основе будущего производства лежит не зависящая от иностранных поставщиков уникальная российская технология, которая может найти применение в ядерной медицине для лечения различных видов онкологических заболеваний. Суммарные инвестиции в проект составляют – 276 500 тыс. руб. Микроисточники радиоактивного излучения (микросферы) на основе радионуклида иттрия-90 предназначаются для терапии коллоректального рака в печень. Актуальность продукта: • Рак печени: 5-е место по распространенности у мужчин, 8-е место у женщин (в мире). • Неоперабельными являются 75-90% всех опухолей печени. • Стандартов лекарственного лечения рака печени не существует. Эффективность: Средняя продолжительность жизни пациента после применения микросфер с иттрием возрастает до 8 лет по сравнению с рутинными методами лечения. Информация об аналогичных способах: регионарная радиотерапия (радиоэмболизация) микросферами SIR-spheres.

• Стадия

  

• Результаты интервью

  ···· ·················· ···· ····.····.·········· ·· ············ ························ ······ ························ ···················· ·············· ························ ······················ ······························ ···························· ·················· ························ ···· ············ ························ ··················».

  ·· ············ ············ ···· ······ ························

  ·· ················ ················ ·················· ·· ····················

  ·· ···················· ······ ················ ··················

  ·· ·················· ···················· ·· ················ ························ ·· ·············· ··················

  ·· ················ ·· ···················· ·· ································ ························ ··················

  ·· ················ ································ ···················· ··················

  ·· ···················· ·· ···················· ························ ····················

  ·· ···················· ···· ························ ························ ······ ························ ····················

  ·· ·················· ·········· ···················· ················ ·························· ····················

  ········ ·························· ·· ········ ·················· ······ ·············· ···· ················

  ·················· ···················· ·· ············ ···················· ·· ······ ······ ········ ········

  ················ ···························· ·· ······················ ······························ ······························ ·················· ·········· ········ ···························· ···················· ······ ······ ········

  ···· ·················· ···· ····.····.·········· ········ ·············· ················ ············ ···· ·············· ···· ················ ···· ·· ················ ···· ·········· ······················ ······ ············ ····························

  ···· ·················· ···· ····.····.········ ······ ·········· ·················· ······ ················ ······················ ················ ···························· ········ ············ ········ ·············· ·· ·········· ·············· ·· ············ ·············· ·············· ·········· ························ ································ ···················· ·············· ···················· ·················· ·· ···················· ·········· ······ ······················ ·················· ················ ······················ ······················ ············ ················ ················ ·· ················ ·················· ······ ····································

• Объем инвестиций

  ········ ····

• Сроки проекта

  2014 — I квартал, 2017 год

• Вид собственности

  Частный

• Отрасль

  Фармацевтическая промышленность

• Подотрасль

  Лекарственные препараты

• Тип объекта

  ·········· ·························· ··············

* Экспертная оценка ПКР

• Производственная мощность

  ················ ······

• Готовая продукция

  ········ ············ ···· ······ ········ ······ ················ ·········· ············ ········

* Экспертная оценка ПКР